Daunorubicin, Cytarabine, and Midostaurin in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia

NCT00651261 · clinicaltrials.gov ↗

PHASE3

Phase

UNKNOWN

Status

717

Enrollment

OTHER

Sponsor class

Conditions

Leukemia

Interventions

DRUG: cytarabine
DRUG: daunorubicin
DRUG: midostaurin
OTHER: placebo
DRUG: dexamethasone acetate

Sponsor

Alliance for Clinical Trials in Oncology

Collaborators

[object Object]
[object Object]